GRIFOLS SA INH. A EO-,25/ ES0171996087 /
2024-04-18 8:56:45 PM | Chg. -0.20 | Volume | Bid9:59:52 PM | Ask9:59:52 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
8.45EUR | -2.31% | 9,104 Turnover: 79,857.69 |
8.51Bid Size: 620 | 8.61Ask Size: 610 | 7.12 bill.EUR | - | 95.76 |
GlobeNewswire
04-18
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at ...
GlobeNewswire
04-04
Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Scree...
GlobeNewswire
2023-11-15
Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous ...